Concepedia
Statistics
Publications
17
Citations
597
H-Index
14
Active since
2004
Affiliations
Bayer (Germany)(Current)
University of Bonn
Bayer (United States)
McMaster University
University of Florida
Dirk Garmann is an author at Bayer (Germany) specializing in medicine, tumor biology, and oxidative stress.
Top concepts
MedicineOncologyCell BiologyPharmacologyLipid ScienceTumor BiologyCancer ResearchDrug ResistanceOxidative StressRadiation Oncology
Publications per year
2004–2023
Synthesis and Biological Activity of Water-Soluble Maleimide Derivatives of the Anticancer Drug Carboplatin Designed as Albumin-Binding Prodrugs
André Warnecke, Iduna Fichtner, Dirk Garmann et al. · Bioconjugate Chemistry · 2004 · 99 citations
Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells
Dirk Garmann, André Warnecke, Ganna V. Kalayda et al. · Journal of Controlled Release · 2008 · 83 citations
Tumor Biology, Cellular Accumulation, Medicine +7
Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations
Stefan Willmann, Liping Zhang, Matthias Frede et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 65 citations · Full text
Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes?
Irina Buß, Dirk Garmann, M. Galanski et al. · Journal of Inorganic Biochemistry · 2011 · 43 citations
Oxysterol, Platinum Complexes, Medicine +5
Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A
Anita Shah, Alexander Solms, Dirk Garmann et al. · Clinical Pharmacokinetics · 2016 · 39 citations · Full text
1–5 of 17